ICD10 code of Minimal change disease and ICD9 code

The ICD-10 code for Minimal change disease is N04.1 (nephrotic syndrome with minor glomerular abnormality), while the legacy ICD-9 code is 581.1. These medical billing codes are essential for clinicians to document Minimal change disease in electronic health records to facilitate insurance processing and clinical tracking.

What exactly is Minimal change disease?

Minimal change disease is a kidney disorder characterized by the loss of specific proteins in the urine (nephrotic syndrome) caused by damage to the tiny blood-filtering units of the kidneys, known as glomeruli. The term "minimal change" refers to the fact that the glomeruli appear normal under a standard light microscope; the actual damage—the fusion of podocyte foot processes—is only visible through an electron microscope. While Minimal change disease is the most common cause of nephrotic syndrome in children, it also affects adults, often presenting with sudden onset of swelling (edema), particularly around the eyes and in the legs.

How is Minimal change disease diagnosed and coded?

Diagnosis of Minimal change disease usually involves a combination of urinalysis, blood tests, and, in many cases, a kidney biopsy to confirm the histological pattern. Clinicians use specific codes to ensure accurate medical records. As noted, the ICD-10 code N04.1 is the primary designation. Understanding these codes helps patients navigate the healthcare system and ensures that their medical journey is accurately captured in clinical registries, such as the 68 members who have shared their experiences with Minimal change disease on DiseaseMaps.org.

What are the common clinical features of Minimal change disease?

Patients with Minimal change disease typically present with a rapid onset of symptoms related to the loss of protein in the urine. Managing these symptoms is a priority for the clinical team. Common clinical markers include:

• Proteinuria: High levels of protein in the urine, often detected via a dipstick or 24-hour urine collection.


• Hypoalbuminemia: Low levels of albumin in the blood, resulting from the kidney's inability to retain protein.


• Edema: Significant swelling, frequently starting in the eyelids or ankles due to fluid retention.


• Hyperlipidemia: Elevated cholesterol and triglyceride levels, often seen as a compensatory response by the liver.

Is Minimal change disease considered a chronic condition?

While many children experience a favorable response to corticosteroid therapy, Minimal change disease can follow a relapsing course for some individuals. The psychological burden of dealing with a chronic or relapsing kidney condition should not be overlooked. Our clinical psychologist team emphasizes that finding support within communities like DiseaseMaps.org can significantly improve quality of life. Understanding that Minimal change disease often requires long-term management helps families prepare for the potential need for steroid-sparing agents or other immunosuppressive therapies if frequent relapses occur.

Next steps

• Consult with a board-certified nephrologist to discuss your specific biopsy results and treatment plan.


• Maintain a detailed log of your urine protein levels and any symptoms of edema to share with your care team.


• Join the patient community at DiseaseMaps.org to connect with others who have been diagnosed with Minimal change disease.


• Ask your physician about the potential for steroid-sparing therapies if you experience frequent relapses.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Nephrotic Syndrome in Children.


• NIH Genetic and Rare Diseases Information Center (GARD) - Minimal change disease entry.


• Orphanet - Rare kidney disease database (ORPHA:65426).


• National Kidney Foundation - Information on Minimal Change Disease.